Questionnaires for Smoking, Cessation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Smoking, Cessation
Questionnaires - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is for smokers who want to change their smoking behaviors and will offer counseling and potentially FDA approved smoking cessation drugs.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 months

6 months
Smoking Abstinence Rate

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Integrated Care (IC) Group
1 of 3
Quitline (QL) Group
1 of 3
Quitline-Rx (QL-Rx) Group
1 of 3
Experimental Treatment

634 Total Participants · 3 Treatment Groups

Primary Treatment: Questionnaires · No Placebo Group · Phase < 1

Integrated Care (IC) GroupExperimental Group · 8 Interventions: Pharmacotherapy Discussion, Carbon Monoxide (CO) Level Test, Questionnaires, Shared Decision Making + Video, Cessation Counseling, Tobacco Treatment Program, Low Dose Computed Tomography Scan, Anti-Smoking Drug · Intervention Types: Behavioral, Other, Behavioral, Other, Behavioral, Behavioral, Procedure, Drug
Quitline (QL) GroupExperimental Group · 7 Interventions: Quitline, Carbon Monoxide (CO) Level Test, Questionnaires, Shared Decision Making + Video, Cessation Counseling, Nicotine Patch, Low Dose Computed Tomography Scan · Intervention Types: Behavioral, Other, Behavioral, Other, Behavioral, Drug, Procedure
Quitline-Rx (QL-Rx) GroupExperimental Group · 8 Interventions: Quitline, Pharmacotherapy Discussion, Carbon Monoxide (CO) Level Test, Questionnaires, Shared Decision Making + Video, Cessation Counseling, Low Dose Computed Tomography Scan, Anti-Smoking Drug · Intervention Types: Behavioral, Behavioral, Other, Behavioral, Other, Behavioral, Procedure, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Quitline
2011
N/A
~820
Questionnaires
2013
Completed Phase 2
~3240
Cessation Counseling
2014
N/A
~530
Nicotine
FDA approved

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

PfizerIndustry Sponsor
4,260 Previous Clinical Trials
7,104,331 Total Patients Enrolled
57 Trials studying Smoking, Cessation
42,490 Patients Enrolled for Smoking, Cessation
M.D. Anderson Cancer CenterLead Sponsor
2,779 Previous Clinical Trials
1,784,385 Total Patients Enrolled
13 Trials studying Smoking, Cessation
3,589 Patients Enrolled for Smoking, Cessation
National Cancer Institute (NCI)NIH
12,989 Previous Clinical Trials
41,298,424 Total Patients Enrolled
83 Trials studying Smoking, Cessation
1,092,156 Patients Enrolled for Smoking, Cessation
Paul Cinciripini, PHD, MS, BSPrincipal InvestigatorM.D. Anderson Cancer Center
2 Previous Clinical Trials
365 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 9 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing and able to undergo low dose CT scan, as determined by radiology team, or have had a lung cancer screen within 30 days of enrollment into this protocol.
You are able to follow verbal and written instructions in English and complete all aspects of the study.
You have an address and telephone number where he/she may be reached.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 3rd, 2021

Last Reviewed: October 2nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Texas100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
University of Texas MD Anderson Cancer Center100.0%
What portion of applicants met pre-screening criteria?
Met criteria75.0%
Did not meet criteria25.0%
Why did patients apply to this trial?
  • "Helping develop new and improved coping strategies and medications for addictive health"
How many prior treatments have patients received?
0100.0%

How responsive is this trial?

Average response time
  • < 2 Days
Most responsive sites:
  1. University of Texas MD Anderson Cancer Center: < 48 hours
Typically responds via
Phone Call100.0%